Pharmaceutical Industry

Yabang Pharmaceutical Industry

The Yabang pharmaceutical sector is led by Jiangsu Yabang Pharmaceutical Group, which oversees seven wholly-owned subsidiaries:

• Jiangsu Yabang Traditional Chinese Medicine Co., Ltd.
• Jiangsu Yabang Johnson Pharmaceutical Co., Ltd.
• Jiangsu Yabang Epson Pharmaceutical Co., Ltd.
• Jiangsu Yabang Shengyuan Pharmaceutical Co., Ltd.
• Changzhou Yabang Pharmaceutical Co., Ltd.
• Changzhou Yabang Pharmaceutical Research Institute Co., Ltd.

Company Overview

Headquartered in Changzhou, Jiangsu Province, Jiangsu Yabang Pharmaceutical Group employs 2,000 staff members, with total assets of 880 million RMB, covering 320,000 square meters and a registered capital of 295 million RMB.

All manufacturing facilities and production lines have obtained national GMP certification, ensuring compliance with Good Manufacturing Practices.

Core Business & Product Portfolio

Yabang Pharmaceutical primarily engages in the production and distribution of chemical drugs and pharmaceutical formulations, with a key focus on antibacterial medications. The company offers over 100 specifications across 10+ dosage forms, including:

• Large-volume & small-volume injections
• Tablets & capsules
• Granules & syrups
• Oral solutions & suspensions
• Eye drops & ointments

Some of its well-known products in the Chinese market include:

• Cefixime capsules
• Roxithromycin capsules
• Cefradine capsules
• Meloxicam dispersible tablets

Commitment to Innovation & Quality

Beyond product quality, Yabang Pharmaceutical continuously invests in research and development (R&D) to meet market demands and international standards. With state-of-the-art production facilities and a highly skilled workforce, the company is solidifying its position as a leading pharmaceutical enterprise in China and the global market.

Hotline: 86 18717817818 – 84 08888 50660